Healthcare101

  Market Overview The allergy diagnostics market encompasses a range of tests and procedures used to identify specific allergens that trigger allergic reactions in individuals. These reactions can manifest in various forms, including skin rashes, respiratory problems, gastrointestinal issues, and anaphylaxis. Accurate and timely diagnosis is crucial for effective allergy management, enabling patients to avoid allergens and receive appropriate treatment. Download PDF Brochure: Market Size and Growth 2022 Market Value: US$4.7 billion 2024 Market Value: US$5.3 billion Projected 2029 Market Value: US$9.8 billion CAGR (2024–2029): 11.0% The projected growth of the allergy diagnostics market is driven by several factors, including: Increasing Prevalence of Allergies: The global prevalence of allergic diseases, such as allergic rhinitis, asthma, food allergies, and eczema, is on the rise. This increase is attributed to various factors, including environmental changes, lifestyle fact...

 This report provides a comprehensive analysis of the monoclonal antibody (mAbs) therapeutics market, projecting its growth from an estimated USD 252.6 billion in 2024 to USD 497.5 billion by 2029. This represents a compound annual growth rate (CAGR) of 14.5% during the forecast period. The report delves into various aspects of the market, including production methods, sources, routes of administration, and therapeutic applications, offering valuable insights for stakeholders in the pharmaceutical and biotechnology industries. Market Overview Monoclonal antibodies (mAbs) have revolutionized the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases. Their ability to specifically target and bind to antigens has made them a powerful tool in modern medicine. The mAbs therapeutics market has experienced significant growth in recent years, driven by factors such as the increasing prevalence of chronic diseases, advancements in antibody engine...